We are live on
!
Find out more
Tonix Pharmaceuticals
TNXP
TNXP
hedge funds and large institutions have $2.14M invested in Tonix Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BC
1
Broadfin Capital
New York
| $1.75M | – | – | – |
|
|
DCM
2
DAFNA Capital Management
Los Angeles,
California
| $164K | – | – | – |
|
3
Morgan Stanley
New York
| $128K | – | – | – |
|
|
RHBC
4
R.H. Bluestein & Co
Birmingham,
Michigan
| $91K | – | – | – |
|
5
First Manhattan
New York
| $9K | – | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $3K | – | – | – |
|
7
Barclays
London,
United Kingdom
| $2K | – | – | – |
|